PF-00562271
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-00562271, covering 2012-06-14 to 2012-06-14. Get the full timeline:
Most recent: Clinical Trial Update: Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms [Phase 1]